MRP and MDR1 gene expression in primary breast carcinomas.

[1]  R. Pirker,et al.  Clinical relevance of drug resistance genes in malignant disease. , 1996, Leukemia.

[2]  D. Neal,et al.  Alterations in expression of the multidrug resistance-associated protein (MRP) gene in high-grade transitional cell carcinoma of the bladder. , 1996, British Journal of Cancer.

[3]  S. Cohn,et al.  Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. , 1996, The New England journal of medicine.

[4]  P. Picci,et al.  Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome. , 1995, The New England journal of medicine.

[5]  P. Sonneveld,et al.  Expression of the multidrug resistance-associated protein (MRP) gene in human cancers. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  Y. Oshika,et al.  Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer. , 1995, British Journal of Cancer.

[7]  G. Giaccone,et al.  Prognostic relevance of P-glycoprotein expression in breast cancer. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  B. Nielsen,et al.  Sequential coexpression of the multidrug resistance genes MRP and mdr1 and their products in VP-16 (etoposide)-selected H69 small cell lung cancer cells. , 1995, Cancer research.

[9]  D. Hipfner,et al.  Detection of the M(r) 190,000 multidrug resistance protein, MRP, with monoclonal antibodies. , 1994, Cancer research.

[10]  P. Vielh,et al.  Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and to immunohistochemical prognostic indicators. , 1994, Journal of the National Cancer Institute.

[11]  M. Haber,et al.  Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma. , 1994, Cancer research.

[12]  F. Baas,et al.  The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  W. Dalton,et al.  Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematopoietic cells. , 1994, Cancer research.

[14]  I. Sugawara,et al.  Expression of multidrug resistance-associated protein (MRP) in anaplastic carcinoma of the thyroid. , 1994, Cancer letters.

[15]  R. Pirker,et al.  P-glycoprotein expression as unfavorable prognostic factor in acute myeloid leukemia. , 1994, Leukemia.

[16]  S. Simon,et al.  Cell biological mechanisms of multidrug resistance in tumors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Barrand,et al.  A 190-kilodalton protein overexpressed in non-P-glycoprotein-containing multidrug-resistant cells and its relationship to the MRP gene. , 1994, Journal of the National Cancer Institute.

[18]  D. Hipfner,et al.  Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. , 1994, Cancer research.

[19]  D. Harrison,et al.  Evaluation of glutathione S-transferase Pi in non-invasive ductal carcinoma of breast. , 1994, British Journal of Cancer.

[20]  B. Sikic,et al.  Clinical trials of modulation of multidrug resistance pharmacokinetic and pharmacodynamic considerations , 1993, Cancer.

[21]  W. Scheithauer,et al.  MDR1 gene expression in primary colorectal carcinomas. , 1993, British Journal of Cancer.

[22]  D. Housman,et al.  p53-dependent apoptosis modulates the cytotoxicity of anticancer agents , 1993, Cell.

[23]  J. Hickman,et al.  bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. , 1993, Cancer research.

[24]  F. Baas,et al.  Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. , 1993, Cancer research.

[25]  M. Slovak,et al.  Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. , 1993, Cancer research.

[26]  A. Duncan,et al.  Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.

[27]  P. Twentyman.  MDR1 (P-glycoprotein) gene expression--implications for resistance modifier trials. , 1992, Journal of the National Cancer Institute.

[28]  I. Ellis,et al.  P-glycoprotein expression in locally advanced breast cancer treated by neoadjuvant chemotherapy. , 1992 .

[29]  V. Ling,et al.  P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. , 1991, The New England journal of medicine.

[30]  R. Pirker,et al.  MDR1 gene expression and prognostic factors in primary breast carcinomas. , 1991, European journal of cancer.

[31]  B. Sikic,et al.  Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity. , 1991, Blood.

[32]  O. Haas,et al.  MDR1 gene expression and treatment outcome in acute myeloid leukemia. , 1991, Journal of the National Cancer Institute.

[33]  P. Borst,et al.  Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies. , 1991, Cancer research.

[34]  F. Kwiatkowski,et al.  Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast carcinoma. , 1991, Journal of the National Cancer Institute.

[35]  A. Gazdar,et al.  Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Raschack,et al.  Reversal of multi‐drug resistance in human KB cell lines by structural analogs of verapamil , 1990, International journal of cancer.

[37]  R. Brown,et al.  Expression of mdr1 and gst-pi in human breast tumours: comparison to in vitro chemosensitivity. , 1990, British Journal of Cancer.

[38]  V. Ling,et al.  Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  J. Schneider,et al.  P-glycoprotein expression in treated and untreated human breast cancer. , 1989, British Journal of Cancer.

[40]  W. T. Beck.  Unknotting the complexities of multidrug resistance: the involvement of DNA topoisomerases in drug action and resistance. , 1989, Journal of the National Cancer Institute.

[41]  W. McGuire,et al.  Electrophoretic analysis of 248 clinical breast cancer specimens for P-glycoprotein overexpression or gene amplification. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  M C Willingham,et al.  Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[43]  I. Pastan,et al.  Expression of Multidrug Resistance Gene in Human Cancers , 1989 .

[44]  I. Pastan,et al.  The multidrug transporter, a double-edged sword. , 1988, The Journal of biological chemistry.

[45]  I. Pastan,et al.  Multiple-drug resistance in human cancer. , 1987, The New England journal of medicine.

[46]  王怡,et al.  P—GLYCOPROTEIN EXPRESSION IN PRIMARY BREAST CANCER , 1995 .

[47]  D. H. Farkas,et al.  Immunohistochemical analysis of P-glycoprotein expression in breast cancer: clinical correlations. , 1995, Annals of clinical and laboratory science.

[48]  M. Daidone,et al.  Expression of P-glycoprotein and in vitro or in vivo resistance to doxorubicin and cisplatin in breast and ovarian cancers. , 1994, European journal of cancer.

[49]  M. Lehnert.  Reversal of P-glycoprotein-associated multidrug resistance: the challenge continues. , 1993, European journal of cancer.

[50]  B. Sikic,et al.  Multidrug Resistance ( mdr l ) Gene Expression in Adult Acute Leukemias : Correlations With Treatment Outcome and In Vitro Drug Sensitivity , 2003 .

[51]  I. Pastan,et al.  Expression of the Multidrug Resistance Gene in Human Cancer , 1991 .

[52]  S. De Placido,et al.  Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer. , 1991, British Journal of Cancer.